Suven divests Rising stake in $56.4-mn deal

December 14, 2021 10:00 pm | Updated 10:00 pm IST - HYDERABAD

Suven Pharmaceuticals on Tuesday said wholly owned U.S. subsidiary Suven Pharma Inc. had divested its entire 25% stake in U.S. firm Rising Pharma Holdings Inc to Raisin Aggregator, L.P. USA, an arm of global alternative investment firm H.I.G. Capital.

The divestment is for a cash consideration of nearly $40.6 million and 7% stake in Raisin Aggregator valued at $15.8 million, Suven said.

H.I.G. is partnering with the current management of Rising Pharmaceuticals, a leading firm in the generic and specialty pharmaceuticals space in the U.S., to continue the company’s strong track record for growth and to support new initiatives such as mergers and acquisitions and new product launches. H.I.G. has made a strategic equity investment in Rising Pharma Holdings and Casper Pharma (collectively Rising Pharmaceuticals). Suven Pharma Inc. will become an investor in the new company as part of deal, the company said in a release.

Suven Pharmaceuticals chairman and MD Venkat Jasti said that the partnership with HIG Capital would create new business opportunities for Suven.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.